Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00941967
What this trial is testing

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 78
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Large-scale testing (Phase 3)Study completedNCT00901901
What this trial is testing

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 732
Testing effectiveness (Phase 2)UnknownNCT06124001
What this trial is testing

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

Who this might be right for
Primary Hepatocellular Carcinoma
CNBG-Virogin Biotech (Shanghai) Ltd. 36
Not applicableStudy completedNCT06390228
What this trial is testing

Impact of Hepatectomy on HCC Recurrence

Who this might be right for
Hepatocellular Carcinoma Stage IRecurrence
Anhui Medical University 197
Testing effectiveness (Phase 2)WithdrawnNCT03782831
What this trial is testing

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableStudy completedNCT01286428
What this trial is testing

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

Who this might be right for
Liver Cancer
Pathfinder Therapeutics 30
Large-scale testing (Phase 3)WithdrawnNCT01452295
What this trial is testing

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

Who this might be right for
Acute Liver Failure
Vital Therapies, Inc.
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableUnknownNCT05859945
What this trial is testing

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT03219372
What this trial is testing

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhoses
Cedars-Sinai Medical Center 1
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Post-approval studies (Phase 4)Looking for participantsNCT06594744
What this trial is testing

Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)Esophageal Varices
Taipei Veterans General Hospital, Taiwan 120
Not applicableStudy completedNCT01423734
What this trial is testing

The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorSecondary Malignant Neoplasm of Liver
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT04770207
What this trial is testing

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Who this might be right for
Hepatocellular CarcinomaSolid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University 100
Testing effectiveness (Phase 2)UnknownNCT01605734
What this trial is testing

TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
PHENYTOIN/SORAFENIB [VA Drug Interaction]Carcinoma, Hepatocellular
Shandong Cancer Hospital and Institute 120
Early research (Phase 1)Study completedNCT00275093
What this trial is testing

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

Who this might be right for
Hepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 130
Testing effectiveness (Phase 2)WithdrawnNCT05886257
What this trial is testing

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Next Page